Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Sanofi's SAR-442970?
SAR-442970 is a monoclonal antibody commercialized by Sanofi, with a leading Phase II program in Hidradenitis Suppurativa. According to Globaldata,...
Data Insights
SAR-442970 by Sanofi for Hidradenitis Suppurativa: Likelihood of Approval
SAR-442970 is under clinical development by Sanofi and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase II...